Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer
Title:
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer
Author:
Perets, R. Bar, J. Rasco, D.W. Ahn, M.-J. Yoh, K. Kim, D.-W. Nagrial, A. Satouchi, M. Lee, D.H. Spigel, D.R. Kotasek, D. Gutierrez, M. Niu, J. Siddiqi, S. Li, X. Cyrus, J. Chackerian, A. Chain, A. Altura, R.A. Cho, B.C.